Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Apple Inc. (AAPL), NIKE, Inc. (NKE): The Mobile Future of Diabetes Treatments

Telcare’s wireless glucose meter is similar to the iBGStar, but it doesn’t require a smartphone. Once it takes a blood glucose reading from a strip, it can directly upload the medical information over cellular networks to their physicians. Users can also track the history of their uploaded data via its Diabetes Pal app for iOS and Android.

Glooko’s app uses a cable to connect to a variety of off-the-shelf glucose meters. The app, which is only available on iOS, takes readings from the meter and makes them available to patients and doctors.

In addition to these meter-reading apps, there is a wide selection of diabetic cookbooks, exercise regimens, carbohydrate trackers, and insulin schedulers available for smartphones.

The Foolish takeaway
An estimated 347 million people in the world have diabetes, which is projected to be the seventh leading cause of death globally by 2030 due to an aging population, more sedentary lifestyles, and unhealthy diets.

Although notable advances have been made in diabetes treatments, such as the experimental inhalable insulin from MannKind Corporation (NASDAQ:MNKD), the biggest challenge for diabetes patients is the maintenance of the disease.

Therefore, it’s encouraging to see mobile technology improve the quality of life for diabetes patients, and this ongoing convergence of health care and mobile tech could lead to major advances in treatments for other diseases as well.

The article The Mobile Future of Diabetes Treatments originally appeared on

Leo Sun owns shares of Apple. The Motley Fool recommends Apple and Nike. The Motley Fool owns shares of Apple and Nike. 

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.